Comfoderm M2 cream for external use 0.1% + 2%, 30 g
Category
Regenerating agents
Scope of the drug
Dermatology
Release form
Cream
Manufacturer country
Russia
Package quantity, pcs
one
Comfoderm M2 cream for plank beds.
approx.
0.1% + 2% tube 30g No. 1
Name ENG
KOMFODERM M2
Clinical and pharmacological group
Preparation with anti-inflammatory and moisturizing action for external use
ATX code
Highly active corticosteroids in combination with other drugs
Dosage
0.1% + 2% x 30g
Structure
100 g of cream contains:
Active substances: methylprednisolone aceponate 100 mg
urea 2 g
Excipients: liquid paraffin (vaseline oil) - 15 g, propylene glycol - 5 g, polysorbate 80 - 1 g, carbomer interpolymer (type A) - 1 g, trometamol - 400 mg, methyl parahydroxybenzoate - 100 mg, purified water - up to 100 g ...
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 2 years
INN / Active ingredient
Methylprednisolone aceponate, Urea
Specifications
Category
Regenerating agents
Scope of the drug
Dermatology
Release form
Cream
Manufacturer country
Russia
Package quantity, pcs
one
Scope of application
Dermatology
Minimum age from
18 years
Way of introduction
Outwardly
Vacation conditions
Without recipe
Brand name
Akrikhin
The amount of the dosage form in the primary package
30 g
Primary packaging type
Tuba
Type of consumer packaging
Pack of cardboard
Dosage form
Cream for external use
Packaging
Box
Dosage (volume) of the substance in the preparation
100 g methylprednisolone aceponate 0.1 g, urea 2 g
Expiration date in days
730
The target audience
Adult
Package weight, g
5
Mode of application
:
Outwardly.
The drug is applied 1 time / day in a thin layer to the affected skin.
As a rule, the duration of continuous daily treatment with ComfodermВ® M2 should not exceed 12 weeks.
When treating patients with facial skin lesions, the course of treatment should not exceed 5 days.
Pharmaco-therapeutic group
:
Topical glucocorticosteroid + keratolytic agent
Anatomical and therapeutic characteristics
:
D07XC Active glucocorticosteroids, in combination with other drugs